Watchlist

Watchlist
Aquinox Pharmaceuticals, Inc. (AQXP)
Aquinox Pharmaceuticals, Inc. (AQXP)
Aquinox Pharmaceuticals (AQXP) Presents At 2018 Bloom Burton & Co. Healthcare Investor Conference - Slideshow
The following slide deck was published by Aquinox Pharmaceuticals, Inc. in conjunction with this Read more …
Aquinox Pharmaceuticals' (AQXP) CEO David Main on Q4 2017 Results - Earnings Call Transcript
Aquinox Pharmaceuticals, Inc. (AQXP) Q4 2017 Earnings Conference Call March 12, 2018 4:30 PM ET Executives Brendan Payne - Associate Director, Investor Relations David Main - President & Chief Executive Officer Barbara Troupin - Chief Medical Officer & VP, Clinical Develo…
Aquinox Pharma misses by $0.11
Aquinox Pharma (NASDAQ: AQXP ): FY EPS of -$2.14 misses by $0.11 . Cash, cash equivalents, short-term and long-term investments of $108.08M Press Release More news on: Aquinox Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news,
ROTY Volume 1 Edition 83: Thank You For Your Patience - Launch Day Has Arrived!
(Editors' Note: This article is meant as an introduction for ROTY , a new Marketplace service by Jonathan Faison). Welcome to the 83rd and final public entry in our Runner of the Year (ROTY) series. First, I want to thank everybody who has been involved in ROTY from the first edition un…
ROTY Edition 1 Volume 82: Launch Preview And Adding To A Position
Welcome to the 82nd entry in our Runner of the Year (ROTY) series. Our model account utilizes a full position size of $10,000 and can hold up to 10 positions. Trades typically occur in quarter increments ($2,500) with cost averages calculated at the day's close. The model account is primaril…
ROTY Edition 1 Volume 81: We Have A Launch Date!
Welcome to the 81st entry in our Runner of the Year (ROTY) series. Our model account utilizes a full position size of $10,000 and can hold up to 10 positions. Trades typically occur in quarter increments ($2,500) with cost averages calculated at the day's close. The model account is primaril…
Aquinox Pharma (AQXP) Presents At Leerink Partners 7th Annual Global Healthcare Conference - Slideshow
The following slide deck was published by Aquinox Pharmaceuticals, Inc. in conjunction with this Read more …
ROTY Edition 1 Volume 80: Adding To Select Positions And Continuing To Manage Risk
Welcome to the 80th entry in our Runner of the Year (ROTY) series. Our model account utilizes a full position size of $10,000 and can hold up to 10 positions. Trades typically occur in quarter increments ($2,500) with cost averages calculated at the day's close. The model account is primaril…
ROTY Edition 1 Volume 79: Limited Downside Catalysts Vs. Binary Risk
Welcome to the 79th entry in our Runner of the Year (ROTY) series. Our model account utilizes a full position size of $10,000 and can hold up to 10 positions. Trades typically occur in quarter increments ($2,500) with cost averages calculated at the day's close. The model account is primaril…
ROTY Edition 1 Volume 78: Simplify Your Decision-Making And Stick To Guidelines
Welcome to the 78th entry in our Runner of the Year (ROTY) series. Our model account utilizes a full position size of $10,000 and can hold up to 10 positions. Trades typically occur in quarter increments ($2,500) with cost averages calculated at the day's close. The model account is primaril…
Aquinox Pharmaceuticals, Inc. (AQXP)